Mira-Martínez Sofía, Zamanillo-Campos Rocío, Malih Narges, Fiol-deRoque Maria Antonia, Angullo-Martínez Escarlata, Jimenez Rafael, Serrano-Ripoll Maria Jesús, Leiva Alfonso, Oña José Iván, Galmes-Panades Aina M, Bennasar-Veny Miquel, Yañez Aina Maria, Gómez-Juanes Rocío, Konieczna Jadwiga, Miralles Jerónima, Romaguera Dora, Vidal-Thomasa María Clara, Llobera-Canaves Joan, García-Toro Mauro, Gervilla-García Elena, Vicens Catalina, Bulilete Oana, Montaño Juan José, Gili Margalida, Roca Miquel, Colom Antoni, Ricci-Cabello Ignacio
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.
Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB), Palma de Mallorca, Spain.
Front Endocrinol (Lausanne). 2025 Mar 31;16:1524336. doi: 10.3389/fendo.2025.1524336. eCollection 2025.
i) to describe PREDIABETEXT, a novel digital intervention for the prevention of type 2 diabetes; ii) to examine the performance of a strategy for virtual recruitment of participants in a trial to assess its impact, and; iii) to determine the baseline characteristics of the enrolled participants.
We developed PREDIABETEXT in a multistage process involving systematic literature reviews and qualitative research with end users (primary care patients and professionals). We combined multiple virtual strategies (SMS, phone calls, promotional videos) to recruit healthcare professionals and their patients. We collected baseline data from patients (sociodemographic, behavioral and clinical) and healthcare professionals (sociodemographic and professional experience).
The intervention consisted in delivering personalized short text messages supporting lifestyle behavior changes to people at risk of type 2 diabetes; and online training to their primary healthcare professionals. We recruited 58/133 (43.6%) professionals (30 doctors; 28 nurses) from 16 centers. Most professionals (83%) were women [mean (SD) age 49.69 (10.15)]. We recruited 365/976 (37.4%) patients (54.5% women, 59.82 (9.77) years old. Around half (55.3%) presented obesity (BMI ≥25), 65% hypertension, 43.3% hypercholesterolemia, and 14.8% hypertriglyceridemia.
The PREDIABETEX trial successfully recruited a representative sample of patients at risk of type 2 diabetes and their healthcare providers.
i)描述PREDIABETEXT,一种用于预防2型糖尿病的新型数字干预措施;ii)研究在一项试验中虚拟招募参与者以评估其影响的策略的效果;iii)确定已招募参与者的基线特征。
我们通过多阶段过程开发了PREDIABETEXT,该过程包括系统的文献综述和与最终用户(初级保健患者和专业人员)的定性研究。我们结合了多种虚拟策略(短信、电话、宣传视频)来招募医疗保健专业人员及其患者。我们收集了患者的基线数据(社会人口统计学、行为和临床数据)以及医疗保健专业人员的基线数据(社会人口统计学和专业经验)。
该干预措施包括向有2型糖尿病风险的人群发送支持生活方式行为改变的个性化短信息,以及为他们的初级医疗保健专业人员提供在线培训。我们从16个中心招募了58/133名(43.6%)专业人员(30名医生;28名护士)。大多数专业人员(83%)为女性,平均(标准差)年龄为49.69(10.15)岁。我们招募了365/976名(37.4%)患者(54.5%为女性,年龄59.82(9.77)岁)。大约一半(55.3%)的患者存在肥胖(BMI≥25),65%患有高血压,43.3%患有高胆固醇血症,14.8%患有高甘油三酯血症。
PREDIABETEX试验成功招募了有2型糖尿病风险的患者及其医疗保健提供者的代表性样本。